======= WBP2 =======
== Gene Information ==
* **Official Symbol**: WBP2
* **Official Name**: WW domain binding protein 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23558|23558]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q969T9|Q969T9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=WBP2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WBP2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606962|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as transcriptional coactivator of estrogen and progesterone receptors (ESR1 and PGR) upon hormone activation (PubMed:16772533). In presence of estrogen, binds to ESR1- responsive promoters (PubMed:16772533). Required for YAP1 coactivation function on PGR activity (PubMed:16772533). Synergizes with WBP2 in enhancing PGR activity (PubMed:16772533). Modulates expression of post-synaptic scaffolding proteins via regulation of ESR1, ESR2 and PGR (By similarity). {ECO:0000250|UniProtKB:P97765, ECO:0000269|PubMed:16772533}.
|WWbp|
|GRAM|
|positive regulation of histone H3-K14 acetylation|
|regulation of histone H3-K14 acetylation|
|progesterone receptor signaling pathway|
|positive regulation of intracellular estrogen receptor signaling pathway|
|positive regulation of intracellular steroid hormone receptor signaling pathway|
|cellular response to estrogen stimulus|
|positive regulation of histone acetylation|
|positive regulation of peptidyl-lysine acetylation|
|regulation of intracellular estrogen receptor signaling pathway|
|positive regulation of protein acetylation|
|estrogen receptor binding|
|response to progesterone|
|regulation of histone acetylation|
|regulation of peptidyl-lysine acetylation|
|positive regulation of gene expression, epigenetic|
|intracellular steroid hormone receptor signaling pathway|
|regulation of protein acetylation|
|chromatin DNA binding|
|response to estrogen|
|regulation of intracellular steroid hormone receptor signaling pathway|
|positive regulation of histone modification|
|positive regulation of chromatin organization|
|steroid hormone mediated signaling pathway|
|regulation of histone modification|
|intracellular receptor signaling pathway|
|hormone-mediated signaling pathway|
|positive regulation of chromosome organization|
|cellular response to steroid hormone stimulus|
|regulation of chromatin organization|
|response to ketone|
|regulation of gene expression, epigenetic|
|nuclear chromatin|
|transcription coactivator activity|
|response to steroid hormone|
|regulation of chromosome organization|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|cellular response to lipid|
|cellular response to organic cyclic compound|
|cellular response to hormone stimulus|
|positive regulation of organelle organization|
|response to lipid|
|response to hormone|
|response to organic cyclic compound|
|response to drug|
|positive regulation of cellular component organization|
|positive regulation of transcription by RNA polymerase II|
|cellular response to endogenous stimulus|
|positive regulation of protein modification process|
|regulation of organelle organization|
|response to endogenous stimulus|
|positive regulation of transcription, DNA-templated|
|response to oxygen-containing compound|
|positive regulation of cellular protein metabolic process|
|establishment of protein localization|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of signal transduction|
|positive regulation of protein metabolic process|
|positive regulation of RNA metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of protein modification process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.11|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7730
* **Expression level (log2 read counts)**: 5.39
{{:chemogenomics:nalm6 dist.png?nolink |}}